NDC 51672-4041-01 - Carbamazepine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-4041
- Requested NDC
- 51672-4041-01
- Package NDCs from labels
- 51672-4041-1, 51672-4041-2, 51672-4041-9, 51672-4041-0, 51672-4041-01
- Manufacturer
- Golden State Medical Supply, Inc.
- Effective date
- 2026-10-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Carbamazepine Tablets USP, (Chewable), 100 mg | Golden State Medical Supply, Inc. | 2026-10-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Carbamazepine - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-09-28 | HUMAN PRESCRIPTION DRUG LABEL |
| Carbamazepine - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-09-24 | HUMAN PRESCRIPTION DRUG LABEL |
| Carbamazepine - NCS HealthCare of KY, LLC dba Vangard Labs | NCS HealthCare of KY, LLC dba Vangard Labs | 2026-09-23 | HUMAN PRESCRIPTION DRUG LABEL |
| Carbamazepine | Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries Ltd. | 2026-08-30 | HUMAN PRESCRIPTION DRUG LABEL |
| Carbamazepine - State of Florida DOH Central Pharmacy | State of Florida DOH Central Pharmacy | 2010-05-20 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-4041-0 | Carbamazepine | 10 in 1 CARTON | TABLET, CHEWABLE | 10 | 11 | |
| 51672-4041-0 | Carbamazepine | 10 in 1 BLISTER PACK | TABLET, CHEWABLE | 10 | 11 | |
| 51672-4041-1 | Carbamazepine | 100 in 1 BOTTLE | TABLET, CHEWABLE | 100 | 11 | |
| 51672-4041-2 | Carbamazepine | 500 in 1 BOTTLE | TABLET, CHEWABLE | 500 | 11 | |
| 51672-4041-9 | Carbamazepine | 5 in 1 CARTON | TABLET, CHEWABLE | 5 | 11 | |
| 51672-4041-9 | Carbamazepine | 10 in 1 BLISTER PACK | TABLET, CHEWABLE | 10 | 11 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-4041 | CARBAMAZEPINE TABLET, CHEWABLE CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, EXTENDED RELEASE CARBAMAZEPINE SUSPENSION [TARO PHARMACEUTICALS U.S.A., INC.] | 9 | Current NDC, Legacy NDC, 6 package rows | 20241127_0526a054-3eda-49b4-b390-7d5d16e30af8.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-4041-1 | EA - Each | 51672-4041 | 4c98a79e-6df5-45c1-b739-16327bfed6db | 1 | 2012-07-24 |
| 51672-4041-2 | EA - Each | 51672-4041 | a1d44adc-0326-41e4-8a02-610906712639 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Walgreens Multi-Symptom Relief Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400, TETRAHYDROZOLINE HCL, ZINC SULFATE | Walgreen Co. | a03789ce-66bd-7b12-e053-2995a90af85a | 2023-12-20 | Warnings | 3NXW29V3WO |
| Walgreens Lubricant Eye Drops Preservative Free | DEXTRAN 70, HYPROMELLOSE | Walgreen Company | 9b383e41-e116-1c12-e053-2a95a90ab25f | 2023-12-20 | Warnings | 3NXW29V3WO |
| Walgreens Lubricant Eye Drops High Performance 15mL and twin pack | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Walgreen Company | 94ee8310-1c19-dfd4-e053-2a95a90a8356 | 2023-12-20 | Warnings | 6DC9Q167V3 |
| Walgreens Lubricant Eye Drops Dry Eye 15mL and twin pack | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Walgreen Company | 94f6e1cd-073c-61ca-e053-2a95a90ae725 | 2023-12-20 | Warnings | 6DC9Q167V3 |
| Kroger High Performance Lubricant Eye Drops | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Kroger | d2aa8963-1922-02f3-e053-2a95a90a7d93 | 2023-12-20 | Warnings | 6DC9Q167V3 |
| TopCare Health Dry Eye Relief Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Topco Associates LLC | 9c617e34-fc66-1a5b-e053-2995a90ace2c | 2023-12-20 | Warnings | 3NXW29V3WO |
| Topcare Health Lubricant Eye Drops | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Topco Assoc LLC | 9c6284f9-00bb-37b5-e053-2a95a90ae2ee | 2023-12-20 | Warnings | 6DC9Q167V3 |
| HEB Dry Eye Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | HEB | f80023cf-8e42-780a-e053-6294a90a66cd | 2023-12-20 | Warnings | 3NXW29V3WO |
| GenTeal Tears (Moderate) | DEXTRAN 70, GLYCERIN, HYPROMELLOSE | Alcon Laboratories, Inc. | a2992597-3490-6a5c-be45-2b6fa15e1547 | 2023-12-15 | Warnings | 3NXW29V3WO |
| SYSTANE HYDRATION PF PRESERVATIVE FREE | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | db3a6c68-320b-46b0-83fa-6c29297a84a6 | 2023-12-15 | Warnings | 6DC9Q167V3 |
| Systane | POLYETHYLENE GLYCOL AND PROPYLENE GLYCOL | Alcon Research Ltd | 14916d2c-a63d-491e-bd91-a61f300af38a | 2023-12-15 | Warnings | 6DC9Q167V3 |
| Systane Lubricant | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 15bc06ec-f3dc-3180-ca1a-106769a770ea | 2023-12-15 | Warnings | 6DC9Q167V3 |
| Systane ULTRA | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | a5c1c194-3db5-4f18-9cd1-97f7f84c3cff | 2023-12-15 | Warnings | 6DC9Q167V3 |
| Systane COMPLETE PF | PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 7eaa93ca-c843-4c89-921b-c76659410dce | 2023-12-14 | Warnings | 6DC9Q167V3 |
| GenTeal Tears Gel Drops | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 84388a75-9d11-48ce-bf5a-88f0580d2d03 | 2023-12-14 | Warnings | 6DC9Q167V3 |
| Oracit | CITRIC ACID AND SODIUM CITRATE | CMP Pharma, Inc. | bc26abed-8e6e-475d-8ab3-abf7d0377003 | 2023-12-07 | Adverse reactions | 2968PHW8QP |
| Eye Wash | WATER | Jiangxi Zhenmei Biological Technology Co.,Ltd | c68795b8-bf68-0d01-e053-2a95a90abebb | 2023-12-04 | Warnings | 059QF0KO0R |
| Phexxi | LACTIC ACID, L-, CITRIC ACID MONOHYDRATE, AND POTASSIUM BITARTRATE | Evofem, Inc. | 173ff411-7227-47b0-94dc-844e1ebaf14e | 2023-11-21 | Warnings, Adverse reactions | 2968PHW8QP |
| Saccharum officinale | SUCROSE | Boiron | 86d04552-b31a-0fcf-e053-2991aa0acecd | 2023-11-14 | C151H8M554 | |
| Saccharum officinale | SUCROSE | Boiron | 86d05561-6f09-6f1f-e053-2a91aa0a4b98 | 2023-11-14 | C151H8M554 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.